IMPORTANT ANNOUNCEMENT

At the end of our start-up phase the organisation and leadership of the Netherlands’ MCRN will undergo several changes.
 
As a positive result of recent discussions with all national stakeholders, the MCRN Coordinating Centre will be moved to Rotterdam, where the coordination will be led by Coordinator Mrs. Tjitske van der Zanden ( This e-mail address is being protected from spambots. You need JavaScript enabled to view it   and wed/thu/fri Tel: +31 10 703 2072), pharmacologist Dr Edwin Spaans, and paediatrician Prof. Dr Ronald de Groot. The new team will continue to carry out MCRN’s tasks and services.
 
All these changes will be  effective per 14 December 2011.
 
On behalf of the outgoing board of Stichting MCRN,
Martin Offringa & Johan Tas

European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) 

The Dutch MCRN has continued its category 1 Enpr-EMA membership as of January 2012 by submitting the annual update of the self assessment report. A copy of the self assessment report can be requested by email ( This e-mail address is being protected from spambots. You need JavaScript enabled to view it ).

History
The European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) is a network of research networks, investigators and centres with recognised expertise in performing clinical studies in children.

Enpr-EMA aims to foster high-quality ethical research on quality, safety and efficacy of medicines to be used in children. It does this through networking and stakeholder collaboration with members from within and outside the European Union (EU).

Following a call for expressions of interest in 2010, the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) published in January 2011 a full listing of applicants for Enpr-EMA membership.  To date a total of 32 networks and centres have submitted self-assessment reports. These documents are published and are categorised according to ability to fulfill the minimum criteria. 

16 networks and centres in category 1 are now members of Enpr-EMA (those in category 2 are currently undergoing clarification before membership of Enpr-EMA while those in category 3 do not currently qualify for membership)

The Dutch

Medicines for Children Research Network

is a

category 1 member of Enpr-EMA